FDA warning: Ozempic, other weight-loss drugs can cause vision loss
The Food and Drug Administration on Monday said popular GLP-1 weight-loss medications such as Ozempic, Wegovy and others must put a warning about greater risks for permanent vision loss on their packaging.
Original Source
Read the full article at Washingtontimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.